{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:42:17Z","timestamp":1793047337030,"version":"4.5.0"},"reference-count":359,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jconrel.2020.12.025","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T23:28:33Z","timestamp":1609370913000},"page":"438-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"special_numbering":"C","title":["Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities"],"prefix":"10.1016","volume":"330","author":[{"given":"Yun-Chu","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryhan F.","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhawal","family":"Chobisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon","family":"Yeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2020.12.025_bb0005","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0010","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/nri2470","article-title":"Annexin A1 and glucocorticoids as effectors of the resolution of inflammation","volume":"9","author":"Perretti","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/intimm\/dxu102","article-title":"Anti-TNF therapy: past, present and future","volume":"27","author":"Monaco","year":"2015","journal-title":"Int. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0020","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/jir.2011.0065","article-title":"Cytokines in autoimmunity: role in induction, regulation, and treatment","volume":"31","author":"Moudgil","year":"2011","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0025","first-page":"1","article-title":"1 local and systemic safety of intranasal corticosteroids","volume":"22","author":"Sastre","year":"2012","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0030","doi-asserted-by":"crossref","first-page":"821","DOI":"10.18433\/J3VW2F","article-title":"Adverse effects of nonsteroidal antiinflammatory drugs: an update of gastrointestinal, cardiovascular and renal complications","volume":"16","author":"Harirforoosh","year":"2013","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0035","series-title":"StatPearls","article-title":"Disease modifying anti-rheumatic drugs (DMARD)","author":"Benjamin","year":"2019"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0040","doi-asserted-by":"crossref","first-page":"6157","DOI":"10.1039\/C4TB00548A","article-title":"Drug-releasing implants: current progress, challenges and perspectives","volume":"2","author":"Santos","year":"2014","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0045","first-page":"1","article-title":"Magnesium, iron and zinc alloys, the trifecta of bioresorbable orthopaedic and vascular implantation-a review","volume":"5","author":"Heiden","year":"2015","journal-title":"J. Biotechnol. Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0050","first-page":"16","article-title":"Drug delivery from structured porous inorganic materials","volume":"4","author":"Arruebo","year":"2012","journal-title":"Wiley Interdiscipl. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0055","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.joca.2013.03.018","article-title":"The epidemiology and impact of pain in osteoarthritis","volume":"21","author":"Neogi","year":"2013","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1159\/000493390","article-title":"Rheumatoid arthritis: a brief overview of the treatment","volume":"27","author":"Bullock","year":"2018","journal-title":"Med. Princ. Pract."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0065","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrrheum.2014.162","article-title":"Emerging regulators of the inflammatory process in osteoarthritis","volume":"11","author":"Liu-Bryan","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0070","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/ten.teb.2009.0447","article-title":"Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model","volume":"16","author":"Allen","year":"2010","journal-title":"Tissue Eng. Part B Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0080","doi-asserted-by":"crossref","DOI":"10.1039\/b814334j","article-title":"Opportunities for nanotechnology-enabled bioactive bone implants","volume":"19","author":"Tran","year":"2009","journal-title":"J. Mater. Chem."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0085","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/cir842","article-title":"Systemic antibiotic therapy for chronic osteomyelitis in adults","volume":"54","author":"Spellberg","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.colsurfb.2017.03.003","article-title":"An overview of hydrogel-based intra-articular drug delivery for the treatment of osteoarthritis","volume":"154","author":"He","year":"2017","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0095","doi-asserted-by":"crossref","first-page":"l6923","DOI":"10.1136\/bmj.l6923","article-title":"Is there a place for intra-articular corticosteroid injections in the treatment of knee osteoarthritis?","volume":"368","author":"Orchard","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/00002281-199909000-00016","article-title":"Intra-articular corticosteroid treatment in osteoarthritis","volume":"11","author":"Creamer","year":"1999","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0105","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/art.1780381104","article-title":"Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee","volume":"38","author":"Hochberg","year":"1995","journal-title":"Am. Coll. Rheumatol. Arthritis Rheum."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0110","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/17453674.1997.11744766","article-title":"The effect of intraarticular hydrocortisone injection on the articular cartilage of rabbits","volume":"275","author":"Papacrhistou","year":"1997","journal-title":"Acta Orthop. Scand. Suppl."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0115","first-page":"107","article-title":"The deterioration of articular cartilage in osteoarthritis by corticosteroid injections","volume":"2","author":"Hauser","year":"2009","journal-title":"J. Prolother."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0120","series-title":"Joint Disease in the Horse","first-page":"215","article-title":"13 - Hyaluronan","author":"Frisbie","year":"2016"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0125","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2018.13134","article-title":"Two new intra-articular injections for knee osteoarthritis (reprinted from the medical letter on drugs and therapeutics vol 60, pg 142-144, 2018)","volume":"320","author":"Abramowicz","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0130","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.nano.2010.10.008","article-title":"Poly(amidoamine) dendrimer-erythromycin conjugates for drug delivery to macrophages involved in periprosthetic inflammation","volume":"7","author":"Bosnjakovic","year":"2011","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0135","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ijpharm.2013.08.016","article-title":"Intra-articular fate of degradable poly(ethyleneglycol)-hydrogel microspheres as carriers for sustained drug delivery","volume":"456","author":"B\u00e9douet","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0140","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.actbio.2019.01.049","article-title":"Cross-linked cellulose nanocrystal aerogels as viable bone tissue scaffolds","volume":"87","author":"Osorio","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0145","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/1535370218787770","article-title":"Localized and targeted delivery of NSAIDs for treatment of inflammation: a review","volume":"244","author":"Haley","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0150","doi-asserted-by":"crossref","first-page":"857","DOI":"10.4155\/tde.12.66","article-title":"Local drug delivery to the bone by drug-releasing implants: perspectives of nano-engineered titania nanotube arrays","volume":"3","author":"Gulati","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0155","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1002\/jps.22497","article-title":"Local drug delivery system: inhibition of inflammatory angiogenesis in a murine sponge model by dexamethasone-loaded polyurethane implants","volume":"100","author":"Moura","year":"2011","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0160","doi-asserted-by":"crossref","first-page":"655","DOI":"10.24425\/124303","article-title":"The inflammatory reaction and the expression of pro- and anti-inflammatory cytokines to a novel polyester-polyurethane aortic prosthesis evaluated in dogs at 6 and 12 months post-implantation","volume":"21","author":"M\u0101lniece","year":"2018","journal-title":"Pol. J. Vet. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0165","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.biopha.2009.08.004","article-title":"Metformin inhibits inflammatory angiogenesis in a murine sponge model","volume":"64","author":"Xavier","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0170","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1007\/s10856-012-4615-5","article-title":"Controlled release of triamcinolone acetonide from polyurethane implantable devices: application for inhibition of inflammatory-angiogenesis","volume":"23","author":"Pinto","year":"2012","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0175","doi-asserted-by":"crossref","first-page":"3731","DOI":"10.1002\/jps.24569","article-title":"Methotrexate locally released from poly(e-caprolactone) implants: inhibition of the inflammatory angiogenesis response in a murine sponge model and the absence of systemic toxicity","volume":"104","author":"De Oliveira","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0180","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jddst.2017.11.012","article-title":"Tacrolimus delivered from polymeric implants suppressed inflammation and angiogenesis in vivo without inducing nephrotoxicity, hepatotoxicity, and myelosuppression","volume":"43","author":"De Oliveira","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0185","first-page":"212","article-title":"Intra-articular leflunomide-loaded poly(epsilon-caprolactone) implants to treat synovitis in rheumatoid arthritis","volume":"74","author":"Gomes","year":"2019","journal-title":"Pharmazie"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0190","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.jconrel.2019.05.039","article-title":"Often neglected: PLGA\/PLA swelling orchestrates drug release: HME implants","volume":"306","author":"Bode","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0195","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/09205063.2015.1125564","article-title":"Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded poly (Caprolactone) microparticles\u2014a potential intra-articular drug delivery system for the treatment of osteoarthritis","volume":"27","author":"Arunkumar","year":"2016","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0200","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jsps.2018.01.006","article-title":"Renewable poly(\u03b4-decalactone) based block copolymer micelles as drug delivery vehicle: in vitro and in vivo evaluation","volume":"26","author":"Bansal","year":"2018","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2019.07.030","article-title":"Triamcinolone acetonide-loaded PLA\/PEG-PDL microparticles for effective intra-articular delivery: synthesis, optimization, in vitro and in vivo evaluation","volume":"309","author":"Abou-ElNour","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0210","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.actbio.2019.03.010","article-title":"Intra-articular targeting of nanomaterials for the treatment of osteoarthritis","volume":"93","author":"Brown","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0215","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1021\/acs.molpharmaceut.7b00484","article-title":"Nanoparticle properties for delivery to cartilage: the implications of disease state, synovial fluid, and off-target uptake","volume":"16","author":"Brown","year":"2017","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0220","article-title":"Rational engineering of ferritin nanocages for targeted therapy of osteoarthritis","volume":"102210","author":"He","year":"2020","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0225","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7150\/thno.16844","article-title":"Scavenger receptor-mediated targeted treatment of collagen-induced arthritis by dextran sulfate-Methotrexate prodrug","volume":"7","author":"Yang","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0230","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.biomaterials.2017.03.044","article-title":"Dextran sulfate nanoparticles as a theranostic nanomedicine for rheumatoid arthritis","volume":"131","author":"Heo","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0235","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.ijbiomac.2020.05.013","article-title":"Dextran sulfate-triamcinolone acetonide conjugate nanoparticles for targeted treatment of osteoarthritis","volume":"158","author":"She","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0240","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.joca.2017.10.003","article-title":"Synovial and systemic pharmacokinetics (PK) of triamcinolone acetonide (TA) following intra-articular (IA) injection of an extended-release microsphere-based formulation (FX006) or standard crystalline suspension in patients with knee osteoarthritis (OA)","volume":"26","author":"Kraus","year":"2018","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0245","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00044011-200121060-00006","article-title":"Sustained-release dexamethasone palmitate","volume":"21","author":"Bias","year":"2001","journal-title":"Clin. Drug Investig."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0250","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/10717544.2019.1660434","article-title":"Biomaterial-engineered intra-articular drug delivery systems for osteoarthritis therapy","volume":"26","author":"Kou","year":"2019","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0255","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s40005-018-0383-7","article-title":"Recent advances in intra-articular drug delivery systems to extend drug retention in joint","volume":"49","author":"Ho","year":"2019","journal-title":"J. Pharm. Investig."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0260","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1517\/17425247.2014.867325","article-title":"Drug delivery systems for intra-articular treatment of osteoarthritis","volume":"11","author":"Kang","year":"2014","journal-title":"Expert Opin. Drug. Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0265","doi-asserted-by":"crossref","first-page":"748909","DOI":"10.1155\/2012\/748909","article-title":"Micro- and nano-carrier mediated intra-articular drug delivery systems for the treatment of osteoarthritis","volume":"2012","author":"Zhang","year":"2012","journal-title":"J. Nanotechnol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0270","doi-asserted-by":"crossref","first-page":"157","DOI":"10.13005\/bpj\/1624","article-title":"Novel drug delivery systems for rheumatoid arthritis: an approach to better patient compliance","volume":"12","author":"Mohanty","year":"2019","journal-title":"Biomed. Pharmacol. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0275","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/03639045.2012.746360","article-title":"Development of meloxicam in situ implant formulation by quality by design principle","volume":"40","author":"Ibrahim","year":"2014","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0280","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1021\/bm3019856","article-title":"Synthesis and characterization of hybrid hyaluronic acid-gelatin hydrogels","volume":"14","author":"Camci-Unal","year":"2013","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0285","doi-asserted-by":"crossref","first-page":"118859","DOI":"10.1016\/j.ijpharm.2019.118859","article-title":"Thermoresponsive Hyalomer intra-articular hydrogels improve monoiodoacetate-induced osteoarthritis in rats","volume":"573","author":"Hanafy","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0290","doi-asserted-by":"crossref","first-page":"7919","DOI":"10.1016\/j.biomaterials.2014.05.064","article-title":"Release behavior and intra-articular biocompatibility of celecoxib-loaded acetyl-capped PCLA-PEG-PCLA thermogels","volume":"35","author":"Petit","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0295","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1021\/acsabm.9b00232","article-title":"Intra-articular treatment of osteoarthritis with diclofenac-conjugated polymer reduces inflammation and pain","volume":"2","author":"Sulistio","year":"2019","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0300","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1002\/jbm.a.36449","article-title":"Injectable hydrogels and nanocomposite hydrogels for cartilage regeneration","volume":"106","author":"Jeznach","year":"2018","journal-title":"J. Biomed. Mater. Res. A"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0305","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1016\/j.biomaterials.2011.05.033","article-title":"Enhanced MSC chondrogenesis following delivery of TGF-\u03b23 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo","volume":"32","author":"Bian","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0310","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1021\/acs.molpharmaceut.0c00126","article-title":"Microparticles-in-thermoresponsive\/bioadhesive hydrogels as a novel integrated platform for effective intra-articular delivery of triamcinolone acetonide","volume":"17","author":"Abou-ElNour","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0315","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40883-020-00154-2","article-title":"An in situ hyaluronic acid-fibrin hydrogel containing drug-loaded nanocapsules for intra-Articular treatment of inflammatory joint diseases","volume":"6","author":"Storozhylova","year":"2020","journal-title":"Regener. Eng. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0320","doi-asserted-by":"crossref","first-page":"13553","DOI":"10.1038\/srep13553","article-title":"Thermosensitive hydrogel containing dexamethasone micelles for preventing postsurgical adhesion in a repeated-injury model","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0325","first-page":"6775","article-title":"Intra-articular injection of etoricoxib-loaded PLGA-PEG-PLGA triblock copolymeric nanoparticles attenuates osteoarthritis progression","volume":"11","author":"Liu","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0330","doi-asserted-by":"crossref","first-page":"e54016","DOI":"10.1371\/journal.pone.0054016","article-title":"Liposomal targeting of prednisolone phosphate to synovial lining macrophages during experimental arthritis inhibits M1 activation but does not favor M2 differentiation","volume":"8","author":"Hofkens","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0335","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11095-008-9562-y","article-title":"Role of particle size in phagocytosis of polymeric microspheres","volume":"25","author":"Champion","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0340","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ijpharm.2015.12.015","article-title":"Effect of particle size on the biodistribution of nano-and microparticles following intra-articular injection in mice","volume":"498","author":"Pradal","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0345","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1136\/ard.57.6.339","article-title":"A method for estimating macromolecular reflection by human synovium, using measurements of intra-articular half lives","volume":"57","author":"Levick","year":"1998","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0350","doi-asserted-by":"crossref","first-page":"16071","DOI":"10.1038\/natrevmats.2016.71","article-title":"Designing hydrogels for controlled drug delivery","volume":"1","author":"Li","year":"2016","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0355","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00281-008-0109-4","article-title":"Advances in the diagnosis and immunotherapy for ocular inflammatory disease","volume":"30","author":"Yeh","year":"2008","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0360","series-title":"Autoimmunity: From Bench to Bedside","article-title":"Autoimmune uveitis","author":"Amador-Patarroyo","year":"2013"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0365","series-title":"Diagnosis & Treatment of Uveitis","author":"Foster","year":"2013"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0370","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1869-5760-3-43","article-title":"Drug-induced uveitis","volume":"3","author":"London","year":"2013","journal-title":"J. Ophthalmic Inflamm. Infect."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0375","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/01.icu.0000434534.32063.5c","article-title":"Drug-induced uveitis","volume":"24","author":"Moorthy","year":"2013","journal-title":"J. Curr. Opin. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaapos.2019.04.008","article-title":"Symptoms in noninfectious uveitis in a pediatric cohort: Initial presentation versus recurrences","volume":"23","author":"Marino","year":"2019","journal-title":"J. AAPOS"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0385","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.preteyeres.2016.12.001","article-title":"Pharmacokinetic aspects of retinal drug delivery","volume":"57","author":"Del Amo","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0390","series-title":"Raviola, The Structural Basis of the Blood-ocular Barriers","first-page":"27","volume":"25","author":"G.J.E.e.r","year":"1977"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0395","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1167\/iovs.04-1051","article-title":"Permeability of retinal pigment epithelium: effects of permeant molecular weight and lipophilicity","volume":"46","author":"Pitkanen","year":"2005","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0400","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the Use of Immunosuppressive Drugs in Patients With Ocular Inflammatory Disorders: Recommendations of an Expert Panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0405","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1590\/S1984-82502010000300024","article-title":"Implants as Drug Delivery Devices for the Treatment of Eye Diseases","volume":"46","author":"Silva","year":"2010","journal-title":"Brazilian Journal of Pharmaceutical Sciences"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0410","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.drudis.2019.05.031","article-title":"Recent advances in intraocular sustained-release drug delivery devices","volume":"24","author":"Cao","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0415","first-page":"113","article-title":"Novel intraocular therapy in non-infectious uveitis of the posterior segment of the eye","volume":"2","author":"Mikhail","year":"2013","journal-title":"J. Med. Hypothesis Discov. Innov. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0420","series-title":"Uveitis: A Practical Guide to the Diagnosis and Treatment of Intraocular Inflammation","author":"Papaliodis","year":"2017"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0425","series-title":"Retisert\u00ae- Prescribing information","author":"U.S. Food and Drug Administration","year":"2005"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0430","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/polym3010193","article-title":"Recent advances in ocular drug delivery systems","volume":"3","author":"Kuno","year":"2011","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0435","series-title":"Uveitis: A Practical Guide to the Diagnosis and Treatment of Intraocular Inflammation","first-page":"317","article-title":"Surgical therapy: retisert implant","author":"Qian","year":"2017"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0440","series-title":"A Guide to Administering YUTIQ\u00ae","first-page":"1","year":"2019"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0445","series-title":"Yutiq\u00ae-Chemistry Review(s)","author":"U.S. Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0450","series-title":"Yutiq\u00ae- Summary Review","author":"U.S. Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0455","series-title":"Yutiq\u00ae-Printed Labeling","author":"U.S. Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0460","series-title":"Ozurdex\u00ae-Summary Review","author":"U.S. Food and Drug Administration","year":"2009"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0465","series-title":"Ozurdex\u00ae-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0470","doi-asserted-by":"crossref","first-page":"780634","DOI":"10.1155\/2013\/780634","article-title":"Drug delivery implants in the treatment of vitreous inflammation","volume":"2013","author":"Wang","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0475","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.addr.2017.07.002","article-title":"Drug delivery devices for retinal diseases","volume":"128","author":"Kaji","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0480","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.addr.2018.03.013","article-title":"Controlled release technology for anti-angiogenesis treatment of posterior eye diseases: current status and challenges","volume":"126","author":"Lau","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0485","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s10792-013-9829-0","article-title":"Evaluations of therapeutic efficacy of intravitreal injected polylactic-glycolic acid microspheres loaded with triamcinolone acetonide on a rabbit model of uveitis","volume":"34","author":"Li","year":"2014","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0490","doi-asserted-by":"crossref","first-page":"165702","DOI":"10.1088\/1361-6528\/aafe36","article-title":"Evaluation of controlled-release triamcinolone acetonide-loaded mPEG-PLGA nanoparticles in treating experimental autoimmune uveitis","volume":"30","author":"Guo","year":"2019","journal-title":"Nanotechnology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0495","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.018","article-title":"Controlled release of corticosteroid with biodegradable nanoparticles for treating experimental autoimmune uveitis","volume":"296","author":"Luo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0500","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2018.05.050","article-title":"Development of fluorometholone-loaded PLGA nanoparticles for treatment of inflammatory disorders of anterior and posterior segments of the eye","volume":"547","author":"Gonzalez-Pizarro","year":"2018","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0505","doi-asserted-by":"crossref","first-page":"6604","DOI":"10.1038\/s41598-018-24545-2","article-title":"Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis","volume":"8","author":"Wong","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0510","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.1167\/iovs.09-4373","article-title":"Treatment of experimental autoimmune uveoretinitis with intravitreal injection of tacrolimus (FK506) encapsulated in liposomes","volume":"51","author":"Zhang","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0515","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40942-019-0186-7","article-title":"In vivo and in vitro toxicity evaluation of liposome-encapsulated sirolimus","volume":"5","author":"Abud","year":"2019","journal-title":"Int. J. Retina Vitreous"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0520","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1167\/iovs.06-1305","article-title":"Downregulation of endotoxin-induced uveitis by intravitreal injection of vasoactive intestinal peptide encapsulated in liposomes","volume":"48","author":"Lajavardi","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0525","doi-asserted-by":"crossref","first-page":"4402","DOI":"10.1039\/C9TB00939F","article-title":"A thermo-sensitive, injectable and biodegradable in situ hydrogel as a potential formulation for uveitis treatment","volume":"7","author":"Zou","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0530","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/10837450.2019.1578370","article-title":"Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits","volume":"24","author":"Alami-Milani","year":"2019","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0535","series-title":"In Vitro and Ex Vivo Evaluation of Nepafenac-Based Cyclodextrin Microparticles for Treatment of Eye Inflammation, Nanomaterials (Basel)","volume":"10","author":"Lorenzo-Veiga","year":"2020"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0540","doi-asserted-by":"crossref","first-page":"110902","DOI":"10.1016\/j.colsurfb.2020.110902","article-title":"Triamcinolone acetonide loaded-cationic nano-lipoidal formulation for uveitis: evidences of improved biopharmaceutical performance and anti-inflammatory activity","volume":"190","author":"Nirbhavane","year":"2020","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0545","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.colsurfb.2018.11.065","article-title":"In-situ forming gels containing fluorometholone-loaded polymeric nanoparticles for ocular inflammatory conditions","volume":"175","author":"Gonzalez-Pizarro","year":"2019","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0550","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies","volume":"114","author":"Zeinab","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0555","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.intimp.2013.05.020","article-title":"Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment","volume":"17","author":"Song","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0560","series-title":"Absorbable Implant Foreign Body Reaction Masquerading as Orbital Cellulitis","first-page":"e1","volume":"35","author":"Shaughness","year":"2019"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0565","first-page":"1","article-title":"Periodontal diseases","volume":"3","author":"Kinane","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0570","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jconrel.2019.06.038","article-title":"Local drug delivery systems in the management of periodontitis: a scientific review","volume":"307","author":"Rajeshwari","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0575","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1600-051X.1986.tb01412.x","article-title":"Depth of penetration in periodontal pockets with oral irrigation","volume":"13","author":"Eakle","year":"1986","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0580","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1600-051X.1991.tb00422.x","article-title":"Comparison of the antimicrobial effect of the application of chlorhexidine gel, amine fluoride gel and stannous fluoride gel in debrided periodontal pockets","volume":"18","author":"Oosterwaal","year":"1991","journal-title":"J. Clin. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0585","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1039\/C6BM00646A","article-title":"Electrospun poly (lactic acid) fibers containing novel chlorhexidine particles with sustained antibacterial activity","volume":"5","author":"Luo","year":"2017","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0590","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.dental.2016.05.002","article-title":"Development of novel electrospun dual-drug fiber mats loaded with a combination of ampicillin and metronidazole","volume":"32","author":"Schkarpetkin","year":"2016","journal-title":"Dent. Mater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0595","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.archoralbio.2017.10.009","article-title":"Development and evaluation of novel biodegradable chitosan based metformin intrapocket dental film for the management of periodontitis and alveolar bone loss in a rat model","volume":"85","author":"Khajuria","year":"2018","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0600","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jddst.2017.09.015","article-title":"Tailoring antibiotic release for the treatment of periodontal infrabony defects using bioactive gelatin-alginate\/apatite nanocomposite films","volume":"43","author":"Madhumathi","year":"2018","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0605","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/03639045.2016.1224895","article-title":"Thiolated alginate-based multiple layer mucoadhesive films of metformin forintra-pocket local delivery: in vitro characterization and clinical assessment","volume":"43","author":"Kassem","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0610","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.msec.2017.08.059","article-title":"Development and evaluation of thymol-chitosan hydrogels with antimicrobial-antioxidant activity for oral local delivery","volume":"81","author":"Echaz\u00fa","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0615","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/10717544.2016.1233591","article-title":"Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis","volume":"24","author":"Nasra","year":"2017","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0620","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.msec.2017.03.054","article-title":"Formulation of thermoreversible gel of cranberry juice concentrate: evaluation, biocompatibility studies and its antimicrobial activity against periodontal pathogens","volume":"75","author":"Rajeshwari","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0625","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1902\/jop.1998.69.5.507","article-title":"The role of local drug delivery in the management of periodontal diseases: a comprehensive review","volume":"69","author":"Greenstein","year":"1998","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0630","doi-asserted-by":"crossref","first-page":"3134","DOI":"10.1016\/j.xphs.2018.08.023","article-title":"Sustained release of minocycline from minocycline-calcium-dextran sulfate complex microparticles for periodontitis treatment","volume":"107","author":"Wu","year":"2018","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0635","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.archoralbio.2018.10.002","article-title":"Topical application of phenytoin or nifedipine-loaded PLGA microspheres promotes periodontal regeneration in vivo","volume":"97","author":"Zhao","year":"2019","journal-title":"Arch. Oral Biol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0640","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.carbpol.2018.01.043","article-title":"Design and biological response of doxycycline loaded chitosan microparticles for periodontal disease treatment","volume":"186","author":"Gjoseva","year":"2018","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0645","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/jre.12481","article-title":"Modulation of periodontitis progression using pH-responsive nanosphere encapsulating metronidazole or N-phenacylthialzolium bromide","volume":"53","author":"Lin","year":"2018","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0650","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejps.2016.10.012","article-title":"Formulation of polysaccharide-based nanoparticles for local administration into the oral cavity","volume":"96","author":"Pistone","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0655","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ijpharm.2016.07.065","article-title":"Development of cetylpyridinium-alginate nanoparticles: a binding and formulation study","volume":"511","author":"Mirti\u010d","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0660","first-page":"5","article-title":"Actisite (tetracycline hydrochloride periodontal fiber): a critique","volume":"16","author":"Baer","year":"1994","journal-title":"Periodontal Clin. Investig."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0665","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1111\/j.1600-0765.1996.tb00518.x","article-title":"Use of the polymeric matrix as internal standard for quantitation of in vivo delivery of tetracycline HCI from Actisite\u00ae tetracycline fiber during periodontal treatment","volume":"31","author":"Litch","year":"1996","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0670","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4103\/0972-124X.84381","article-title":"Evaluation of commercially available biodegradable tetracycline fiber therapy in chronic periodontitis","volume":"15","author":"Sachdeva","year":"2011","journal-title":"J. Indian Soc. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0675","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1902\/jop.2008.070308","article-title":"Clinical and microbiologic effects of subgingival controlled-release delivery of chlorhexidine chip in the treatment of periodontitis: a multicenter study","volume":"79","author":"Paolantonio","year":"2008","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0680","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1902\/jop.1999.70.5.490","article-title":"Two multi-center studies evaluating locally delivered doxycycline hyclate, placebo control, oral hygiene, and scaling and root planing in the treatment of periodontitis","volume":"70","author":"Garrett","year":"1999","journal-title":"J. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0685","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0972-124X.94603","article-title":"A comparative evaluation of atrigel delivery system (10% doxycycline hyclate) Atridox with scaling and root planing and combination therapy in treatment of periodontitis: a clinical study","volume":"16","author":"Javali","year":"2012","journal-title":"J. Indian Soc. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0690","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1600-0501.2006.01269.x","article-title":"Antimicrobial therapy using a local drug delivery system (Arestin\u00ae) in the treatment of peri-implantitis. I: microbiological outcomes","volume":"17","author":"Persson","year":"2006","journal-title":"Clin. Oral Implants Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0695","doi-asserted-by":"crossref","first-page":"516","DOI":"10.3390\/molecules25030516","article-title":"Emerging applications of drug delivery systems in oral infectious diseases prevention and treatment","volume":"25","author":"Liang","year":"2020","journal-title":"Molecules"},{"issue":"62","key":"10.1016\/j.jconrel.2020.12.025_bb0700","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0757.2012.00450.x","article-title":"Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts","volume":"2000","author":"Bartold","year":"2013","journal-title":"Periodontology"},{"issue":"48","key":"10.1016\/j.jconrel.2020.12.025_bb0705","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1600-0757.2008.00252.x","article-title":"Host response modulation in periodontics","volume":"2000","author":"Preshaw","year":"2008","journal-title":"Periodontology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0710","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1600-0765.2007.01069.x","article-title":"Role of systemic and local administration of selective inhibitors of cyclo-oxygenase 1 and 2 in an experimental model of periodontal disease in rats","volume":"44","author":"Queiroz-Junior","year":"2009","journal-title":"J. Periodontal Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0715","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0972-124X.85670","article-title":"The effect of ketoprofen in chronic periodontitis: a clinical double-blind study","volume":"15","author":"Srinivas","year":"2011","journal-title":"J. Indian Soc. Periodontol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0720","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.actbio.2019.01.001","article-title":"An injectable and thermosensitive hydrogel: promoting periodontal regeneration by controlled-release of aspirin and erythropoietin","volume":"86","author":"Xu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0725","doi-asserted-by":"crossref","first-page":"118564","DOI":"10.1016\/j.ijpharm.2019.118564","article-title":"In-situ forming implants loaded with chlorhexidine and ibuprofen for periodontal treatment: proof of concept study in vivo","volume":"569","author":"Batool","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0730","doi-asserted-by":"crossref","first-page":"5137","DOI":"10.1016\/j.biomaterials.2007.08.014","article-title":"An in vivo study of the host tissue response to subcutaneous implantation of PLGA-and\/or porcine small intestinal submucosa-based scaffolds","volume":"28","author":"Kim","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0735","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1017\/S0022215110001003","article-title":"Outcome of endoscopic sinus surgery for chronic rhinosinusitis patients: a Canadian experience","volume":"124","author":"Al Badaai","year":"2010","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0740","series-title":"International Forum of Allergy & Rhinology","first-page":"88","article-title":"Atopic profile of patients failing medical therapy for chronic rhinosinusitis","author":"Tan","year":"2011"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0745","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1398-9995.2011.02646.x","article-title":"Chronic rhinosinusitis in Europe\u2013an underestimated disease. A GA2LEN study","volume":"66","author":"Hastan","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0750","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens","year":"2012","journal-title":"Rhinology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0755","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1586\/ers.10.49","article-title":"Controversies in the treatment of chronic rhinosinusitis","volume":"4","author":"Guilemany","year":"2010","journal-title":"Expert Rev. Respirator. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0760","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.jaip.2016.05.004","article-title":"Phenotypes and emerging endotypes of chronic rhinosinusitis","volume":"4","author":"Bachert","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0765","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.jaci.2013.02.036","article-title":"Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology","volume":"131","author":"Akdis","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0770","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/pharmaceutics6020249","article-title":"Drug-eluting nasal implants: formulation, characterization, clinical applications and challenges","volume":"6","author":"Parikh","year":"2014","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0775","series-title":"International Forum of Allergy & Rhinology","first-page":"370","article-title":"Risk factors for development of chronic rhinosinusitis in patients with allergic rhinitis","author":"Sedaghat","year":"2012"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0780","series-title":"International Forum of Allergy & Rhinology","first-page":"S22","article-title":"International consensus statement on allergy and rhinology: rhinosinusitis","author":"Orlandi","year":"2016"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0785","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1080\/1744666X.2016.1220833","article-title":"Chronic rhinosinusitis: the rationale for current treatments","volume":"13","author":"Ghogomu","year":"2017","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0790","series-title":"International Forum of Allergy & Rhinology","first-page":"417","article-title":"Early postoperative care following endoscopic sinus surgery: an evidence-based review with recommendations","author":"Rudmik","year":"2011"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0795","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1067\/mai.2002.122458","article-title":"Chronic sinusitis in severe asthma is related to sputum eosinophilia","volume":"109","author":"Grootendorst","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0800","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1183\/09031936.06.00022606","article-title":"Risk factors of frequent exacerbations in difficult-to-treat asthma","volume":"27","author":"Butler","year":"2006","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0805","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/1465-9921-11-163","article-title":"Multi-symptom asthma is closely related to nasal blockage, rhinorrhea and symptoms of chronic rhinosinusitis-evidence from the West Sweden Asthma Study","volume":"11","author":"L\u00f6tvall","year":"2010","journal-title":"Respir. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0810","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1398-9995.2011.02709.x","article-title":"Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe","volume":"67","author":"Jarvis","year":"2012","journal-title":"Allergy"},{"issue":"4","key":"10.1016\/j.jconrel.2020.12.025_bb0815","article-title":"Systemic and topical antibiotics for chronic rhinosinusitis","author":"Head","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0820","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/lary.24100","article-title":"Primary care and upfront computed tomography scanning in the diagnosis of chronic rhinosinusitis: a cost-based decision analysis","volume":"124","author":"Leung","year":"2014","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0825","series-title":"International Forum of Allergy & Rhinology","first-page":"104","article-title":"Oral corticosteroids in the management of adult chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations","author":"Poetker","year":"2013"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0830","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/j.jaci.2012.01.079","article-title":"Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy","volume":"129","author":"Wen","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0835","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/S0140-6736(06)69288-X","article-title":"The mechanisms, diagnosis, and management of severe asthma in adults","volume":"368","author":"Holgate","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0840","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1165\/rcmb.2008-0028OC","article-title":"Steroid-resistant neutrophilic inflammation in a mouse model of an acute exacerbation of asthma","volume":"39","author":"Ito","year":"2008","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0845","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jaci.2004.10.036","article-title":"Oral corticosteroids decrease eosinophil and CC chemokine expression but increase neutrophil, IL-8, and IFN-\u03b3\u2013inducible protein 10 expression in asthmatic airway mucosa","volume":"115","author":"Fukakusa","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0850","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/01.mlg.0000191560.53555.08","article-title":"A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis","volume":"116","author":"Wallwork","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0855","doi-asserted-by":"crossref","first-page":"125","DOI":"10.2147\/DDDT.S25199","article-title":"Novel drug-delivery systems for patients with chronic rhinosinusitis","volume":"6","author":"Albu","year":"2012","journal-title":"Drug Des. Develop. Ther."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0860","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.otc.2016.08.011","article-title":"Topical therapies for refractory chronic rhinosinusitis","volume":"50","author":"Sanan","year":"2017","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0865","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/jam.2007.0569","article-title":"Devices for aerosol delivery to treat sinusitis","volume":"20","author":"Laube","year":"2007","journal-title":"J. Aerosol Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0870","series-title":"International Forum of Allergy & Rhinology","first-page":"S9","article-title":"Topical corticosteroid irrigations in chronic rhinosinusitis","author":"Grayson","year":"2019"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0875","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1002\/lary.28152","article-title":"Intranasal corticosteroids and saline: usage and adherence in chronic rhinosinusitis patients","volume":"130","author":"Phillips","year":"2020","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0880","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1002\/lary.21847","article-title":"Health state utility values in patients undergoing endoscopic sinus surgery","volume":"121","author":"Soler","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0885","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/0194599810391852","article-title":"Cost burden of chronic rhinosinusitis: a claims-based study","volume":"144","author":"Bhattacharyya","year":"2011","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0890","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2147\/IJGM.S29977","article-title":"Chronic rhinosinusitis and emerging treatment options","volume":"6","author":"Piromchai","year":"2013","journal-title":"Int. J. Gen. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0895","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1002\/lary.20653","article-title":"Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis","volume":"119","author":"Hopkins","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0900","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.amjoto.2008.12.006","article-title":"Operative findings in the frontal recess at time of revision surgery","volume":"31","author":"Otto","year":"2010","journal-title":"Am. J. Otolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0905","first-page":"1","article-title":"A corticosteroid-eluting sinus implant following endoscopic sinus surgery for chronic rhinosinusitis: a UK-based cost-effectiveness analysis","author":"Javanbakht","year":"2020","journal-title":"PharmacoEconomics-Open"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0910","series-title":"International Forum of Allergy & Rhinology","first-page":"S22","article-title":"Topical therapies for management of chronic rhinosinusitis: steroid implants","author":"Han","year":"2019"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0915","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.actbio.2020.04.012","article-title":"Recent advances in the implant-based drug delivery in otorhinolaryngology","volume":"108","author":"Tan","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0920","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.otc.2012.06.006","article-title":"Evidence-based practice: postoperative care in endoscopic sinus surgery","volume":"45","author":"Rudmik","year":"2012","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0925","doi-asserted-by":"crossref","first-page":"4","DOI":"10.5319\/wjo.v8.i1.4","article-title":"Effect of intranasal stents (AlaxoLito, AlaxoLito Plus and AlaxoLito Xtreme) on the nasal airway: a case report","volume":"8","author":"Zhang","year":"2019","journal-title":"World J. Otorhinolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0935","series-title":"International Forum of Allergy & Rhinology","first-page":"477","article-title":"Middle meatal spacers for the prevention of synechiae following endoscopic sinus surgery: a systematic review and meta-analysis of randomized controlled trials","author":"Lee","year":"2012"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0940","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.otc.2009.07.009","article-title":"Advances in absorbable biomaterials and nasal packing","volume":"42","author":"Valentine","year":"2009","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0945","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.otc.2017.01.006","article-title":"Advances in absorbable biomaterials and nasal packing","volume":"50","author":"Massey","year":"2017","journal-title":"Otolaryngol. Clin. N. Am."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0950","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00405-008-0841-3","article-title":"Endoscopic outcomes of resorbable nasal packing after functional endoscopic sinus surgery: a multicenter prospective randomized controlled study","volume":"266","author":"Berlucchi","year":"2009","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0955","first-page":"862","article-title":"The clinical effects of hyaluronic acid ester nasal dressing (Merogel) on intranasal wound healing after functional endoscopic sinus surgery, otolaryngology\u2014head and neck","volume":"128","author":"Miller","year":"2003","journal-title":"Surgery"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0960","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0022-3468(98)90317-7","article-title":"Hyaluronan induces scarless repair in mouse limb organ culture","volume":"33","author":"Iocono","year":"1998","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0965","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00405-009-1117-2","article-title":"Use of CMC foam sinus dressing in FESS","volume":"267","author":"Szczygielski","year":"2010","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0970","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.matlet.2014.06.056","article-title":"Wound healing analysis of pectin\/carboxymethyl cellulose\/microfibrillated cellulose based composite scaffolds","volume":"132","author":"Ninan","year":"2014","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0975","article-title":"Prospective, double-blind, randomized trial evaluating patient satisfaction, bleeding, and wound healing using biodegradable synthetic polyurethane foam (NasoPore) as a middle meatal spacer in functional endoscopic sinus surgery","volume":"38","author":"Shoman","year":"2009","journal-title":"J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0980","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/lary.20905","article-title":"Triamcinolone-impregnated nasal dressing following endoscopic sinus surgery: a randomized, double-blind, placebo-controlled study","volume":"120","author":"C\u00f4t\u00e9","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0985","series-title":"International Forum of Allergy & Rhinology","first-page":"248","article-title":"Effect of a dexamethasone Sinu-FoamTM middle meatal spacer on endoscopic sinus surgery outcomes: A randomized, double-blind, placebo-controlled trial","author":"Rudmik","year":"2012"},{"key":"10.1016\/j.jconrel.2020.12.025_bb0990","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1080\/10837450.2017.1389956","article-title":"Intranasal drug delivery devices and interventions associated with post-operative endoscopic sinus surgery","volume":"23","author":"Dkhar","year":"2018","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb0995","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamaoto.2019.0150","article-title":"Off-label treatment in otolaryngology\u2014a cautionary tale","volume":"145","author":"Rathi","year":"2019","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1000","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s12070-011-0258-y","article-title":"The MicroFlow spacer: a drug-eluting stent for the ethmoid sinus","volume":"63","author":"Catalano","year":"2011","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/coa.13515","article-title":"Ethmoidal drug-eluting stent therapy is not superior to nasal corticosteroid spray in the prevention of endoscopic sinus surgery: results from a randomised, clinical trial","volume":"45","author":"Taulu","year":"2020","journal-title":"Clin. Otolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1010","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s00405-002-0534-2","article-title":"Innovative frontal sinus stent acting as a local drug-releasing system","volume":"260","author":"Hosemann","year":"2003","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1015","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1097\/MLG.0b013e3181820896","article-title":"Effects of topically applied dexamethasone on mucosal wound healing using a drug-releasing stent","volume":"118","author":"Beule","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1524-475X.2008.00429.x","article-title":"Pilot study using doxycycline-releasing stents to ameliorate postoperative healing quality after sinus surgery","volume":"16","author":"Huvenne","year":"2008","journal-title":"Wound Repair Regen."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1025","series-title":"Google Patents","article-title":"Sinus and nasal stent","author":"Wen","year":"2018"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1030","article-title":"Stent hypersensitivity and infection in sinus cavities","volume":"4","author":"Kounis","year":"2013","journal-title":"Aller. Rhinol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1035","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.mattod.2017.05.002","article-title":"The current status of biodegradable stent to treat benign luminal disease","volume":"20","author":"Zhu","year":"2017","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1040","series-title":"International Forum of Allergy & Rhinology","first-page":"23","article-title":"Safety and efficacy of a novel bioabsorbable, steroid-eluting sinus stent","author":"Murr","year":"2011"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1045","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1002\/lary.22228","article-title":"ADVANCE: a multisite trial of bioabsorbable steroid-eluting sinus implants","volume":"121","author":"Forwith","year":"2011","journal-title":"Laryngoscope"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1050","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/0194599811435968","article-title":"Advance II: a prospective, randomized study assessing safety and efficacy of bioabsorbable steroid-releasing sinus implants","volume":"146","author":"Marple","year":"2012","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1055","series-title":"PROPEL\u00ae (Mometasone Furoate Implant, 370 \u03bcg) Instructions for Use","author":"Inc","year":"2020"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1060","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1586\/ers.12.53","article-title":"The PROPEL\u2122 steroid-releasing bioabsorbable implant to improve outcomes of sinus surgery","volume":"6","author":"Kennedy","year":"2012","journal-title":"Expert Rev. Respirator. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1065","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1517\/17425247.2013.839654","article-title":"Sinus implants for chronic rhinosinusitis: technology evaluation","volume":"10","author":"Lee","year":"2013","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1070","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1080\/17425247.2016.1250740","article-title":"Evaluation of the PROPEL\u00ae mini sinus implant for the treatment of frontal sinus disease","volume":"13","author":"Santarelli","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1075","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1080\/17512433.2018.1549485","article-title":"Mometasone furoate sinus implant\u2013a new targeted approach to treating recurrent nasal polyp disease","volume":"11","author":"Shen","year":"2018","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/inventions3010001","article-title":"The use of 3D printing in the fabrication of nasal stents","volume":"3","author":"Mills","year":"2018","journal-title":"Inventions"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1085","first-page":"81","article-title":"Meeting on IC\/PBS: outcome of the Consensus meeting on interstitial cystitis\/painful bladder syndrome, February 10, 2007, Washington, DC","volume":"9","author":"Chancellor","year":"2007","journal-title":"Rev. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1090","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0143316","article-title":"Hunner-type (classic) interstitial cystitis: a distinct inflammatory disorder characterized by pancystitis, with frequent expansion of clonal B-cells and epithelial denudation","volume":"10","author":"Maeda","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2006.03.084","article-title":"The role of the urinary epithelium in the pathogenesis of interstitial cystitis\/prostatitis\/urethritis","volume":"69","author":"Parsons","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1756287211398255","article-title":"Role of inflammation in bladder function and interstitial cystitis","volume":"3","author":"Grover","year":"2011","journal-title":"Ther. Adv. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1105","first-page":"29","article-title":"New approaches in managing interstitial cystitis\/bladder pain syndrome","volume":"41","author":"Jerauld","year":"2016","journal-title":"US Pharm."},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2020.12.025_bb1110","first-page":"S16","article-title":"Treatment approaches for interstitial cystitis: multimodality therapy","volume":"4","author":"Evans","year":"2002","journal-title":"Rev. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00003081-200203000-00027","article-title":"Interstitial cystitis: a pathophysiology and treatment update","volume":"45","author":"Moldwin","year":"2002","journal-title":"Clin. Obstet. Gynecol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1120","first-page":"145","article-title":"Intravesical instillation of pentosan polysulfate encapsulated in a liposome nanocarrier for interstitial cystitis","volume":"2","author":"Lander","year":"2014","journal-title":"Am. J. Clin. Exp. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1125","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jconrel.2010.08.031","article-title":"Intravesical drug delivery: challenges, current status, opportunities and novel strategies","volume":"148","author":"GuhaSarkar","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1130","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.21037\/tau.2017.06.18","article-title":"Interstitial cystitis intravesical therapy","volume":"6","author":"Ha","year":"2017","journal-title":"Transl. Androl. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1135","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.urology.2003.10.034","article-title":"Treatment of interstitial cystitis","volume":"63","author":"Chancellor","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1140","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1442-2042.2012.03135.x","article-title":"Intravesical hyaluronic acid for interstitial cystitis\/painful bladder syndrome: a comparative randomized assessment of different regimens","volume":"20","author":"Lai","year":"2013","journal-title":"Int. J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1145","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.actbio.2015.02.030","article-title":"Hyaluronic acid decreases IL-6 and IL-8 secretion and permeability in an inflammatory model of interstitial cystitis","volume":"19","author":"Rooney","year":"2015","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1150","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0022-5347(01)65669-6","article-title":"Intravesical capsaicin for treatment of severe bladder pain: a randomized placebo controlled study","volume":"156","author":"Lazzeri","year":"1996","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1155","doi-asserted-by":"crossref","first-page":"e82591","DOI":"10.1371\/journal.pone.0082591","article-title":"Intravesical resiniferatoxin for the treatment of storage lower urinary tract symptoms in patients with either interstitial cystitis or detrusor overactivity: a meta-analysis","volume":"8","author":"Guo","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1160","series-title":"Bladder Disease, Part A","first-page":"359","article-title":"The effect of intravesical capsaicin and resiniferatoxin in neurogenic bladder dysfunction","author":"El-Mahrouky","year":"2003"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1165","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3390\/toxins8070201","article-title":"Botulinum toxin A for bladder pain syndrome\/interstitial cystitis","volume":"8","author":"Chiu","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1170","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0022-5347(17)38437-9","article-title":"Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis)","volume":"145","author":"Parsons","year":"1991","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1175","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/j.1464-410X.2010.09496.x","article-title":"Pharmacokinetic study to optimize the intravesical administration of gemcitabine","volume":"106","author":"Gontero","year":"2010","journal-title":"BJU Int."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1180","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/jnci\/93.8.597","article-title":"Methods to improve efficacy of intravesical mitomycin C: results of a randomized phase III trial","volume":"93","author":"Au","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1185","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/01.ju.0000080568.91703.18","article-title":"Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study","volume":"170","author":"Di Stasi","year":"2003","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1190","first-page":"169","article-title":"Novel targeted bladder drug-delivery systems: a review","volume":"7","author":"Zacche","year":"2015","journal-title":"Res. Rep. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1195","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1517\/17425247.2016.1100166","article-title":"Advances in intravesical therapy for urinary tract disorders","volume":"13","author":"Tyagi","year":"2016","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1200","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/CMR.00019-07","article-title":"Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis","volume":"21","author":"Jacobsen","year":"2008","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1205","first-page":"1","article-title":"The future of bladder control\u2014intravesical drug delivery, a pinch of pepper, and gene therapy","volume":"4","author":"Fraser","year":"2002","journal-title":"Rev. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1210","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5213\/inj.1632664.332","article-title":"Implantable devices for sustained, intravesical drug delivery","volume":"20","author":"Lee","year":"2016","journal-title":"Int. Neurourol. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1215","doi-asserted-by":"crossref","first-page":"143ra100","DOI":"10.1126\/scitranslmed.3003804","article-title":"Continuous intravesical lidocaine treatment for interstitial cystitis\/bladder pain syndrome: safety and efficacy of a new drug delivery device","volume":"4","author":"Nickel","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1220","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jconrel.2010.10.016","article-title":"An intravesical device for the sustained delivery of lidocaine to the bladder","volume":"149","author":"Lee","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1235","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1038\/s41598-018-24239-9","article-title":"Potential orphan drug therapy of intravesical liposomal onabotulinumtoxin-a for ketamine-induced cystitis by mucosal protection and anti-inflammation in a rat model","volume":"8","author":"Lee","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1240","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.4111\/icu.2020.61.S1.S33","article-title":"Clinical application of intravesical botulinum toxin type A for overactive bladder and interstitial cystitis","volume":"61","author":"Chen","year":"2020","journal-title":"Investig. Clin. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1245","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.juro.2014.07.008","article-title":"Bladder instillation of liposome encapsulated onabotulinumtoxina improves overactive bladder symptoms: a prospective, multicenter, double-blind, randomized trial","volume":"192","author":"Chuang","year":"2014","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1250","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8030081","article-title":"Potential effect of liposomes and liposome-encapsulated botulinum toxin and tacrolimus in the treatment of bladder dysfunction","volume":"8","author":"Janicki","year":"2016","journal-title":"Toxins"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1255","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/nau.20981","article-title":"Intravesical immune suppression by liposomal tacrolimus in cyclophosphamide-induced inflammatory cystitis","volume":"30","author":"Chuang","year":"2011","journal-title":"Neurourol. Urodyn."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1265","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.juro.2012.10.123","article-title":"Development of potential orphan drug therapy of intravesical liposomal tacrolimus for hemorrhagic cystitis due to increased local drug exposure","volume":"189","author":"Nirmal","year":"2013","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1270","doi-asserted-by":"crossref","first-page":"27011","DOI":"10.1074\/jbc.M111.256982","article-title":"Studies of the mechanistic details of the pH-dependent association of botulinum neurotoxin with membranes","volume":"286","author":"Mushrush","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1275","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.juro.2009.03.083","article-title":"Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin a delivery using liposomes","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0122766","article-title":"Bladder uptake of liposomes after intravesical administration occurs by endocytosis","volume":"10","author":"Rajaganapathy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1285","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s11255-014-0828-5","article-title":"Liposomal bladder instillations for IC\/BPS: an open-label clinical evaluation","volume":"46","author":"Peters","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1290","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0090-4295(02)02281-1","article-title":"Intravesical liposome administration\u2014a novel treatment for hyperactive bladder in the rat","volume":"61","author":"Fraser","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1295","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/j.1464-410X.2007.07334.x","article-title":"Activity of different phospholipids in attenuating hyperactivity in bladder irritation","volume":"101","author":"Tyagi","year":"2008","journal-title":"BJU Int."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1300","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/j.juro.2009.06.024","article-title":"Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis\/painful bladder syndrome","volume":"182","author":"Chuang","year":"2009","journal-title":"J. Urol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1305","doi-asserted-by":"crossref","first-page":"267","DOI":"10.3390\/polym10030267","article-title":"Chitosan and its derivatives for application in mucoadhesive drug delivery systems","volume":"10","author":"Ways","year":"2018","journal-title":"Polymers"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1310","doi-asserted-by":"crossref","first-page":"146329","DOI":"10.1155\/2015\/146329","article-title":"Thiomers: a blessing to evaluating era of pharmaceuticals","volume":"2015","author":"Hanif","year":"2015","journal-title":"Int. J. Polym. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1315","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1021\/bm800276d","article-title":"Why is chitosan mucoadhesive?","volume":"9","author":"Sogias","year":"2008","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1320","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0939-6411(03)00061-4","article-title":"Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins","volume":"56","author":"Leitner","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1325","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.ijpharm.2016.08.026","article-title":"Adhesion of thiolated silica nanoparticles to urinary bladder mucosa: effects of PEGylation, thiol content and particle size","volume":"512","author":"Mun","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1330","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijpharm.2011.06.033","article-title":"Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder","volume":"416","author":"Barthelmes","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1335","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.2147\/IJN.S93750","article-title":"Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan\/poloxamer gels as carriers","volume":"10","author":"\u015eenyi\u011fit","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3233\/BLC-180182","article-title":"Thermo reversible hydrogel based delivery of mitomycin C (UGN-101) for treatment of upper tract urothelial carcinoma (UTUC)","volume":"5","author":"Kleinmann","year":"2019","journal-title":"Bladder Cancer"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1345","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1023\/B:PHAM.0000026436.62869.9c","article-title":"Sustained intravesical drug delivery using thermosensitive hydrogel","volume":"21","author":"Tyagi","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1350","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.tibtech.2019.12.012","article-title":"Intravesical hydrogels as drug reservoirs","volume":"38","author":"Qiu","year":"2020","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1355","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.urology.2017.12.028","article-title":"Safety and feasibility of intravesical instillation of botulinum toxin-a in hydrogel-based slow-release delivery system in patients with interstitial cystitis-bladder pain syndrome: a pilot study","volume":"114","author":"Rappaport","year":"2018","journal-title":"Urology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1360","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/jps.23854","article-title":"In situ floating hydrogel for intravesical delivery of adriamycin without blocking urinary tract","volume":"103","author":"Lin","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1365","doi-asserted-by":"crossref","DOI":"10.3390\/ma9121005","article-title":"Floating hydrogel with self-generating micro-bubbles for intravesical instillation","volume":"9","author":"Lin","year":"2016","journal-title":"Materials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1370","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.3109\/10717544.2015.1101791","article-title":"Visualized intravesical floating hydrogel encapsulating vaporized perfluoropentane for controlled drug release","volume":"23","author":"Zhu","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1380","doi-asserted-by":"crossref","first-page":"489173","DOI":"10.1260\/2040-2295.3.4.535","article-title":"Applications of nanotechnology in bladder cancer therapy","volume":"3","author":"Hsu","year":"2012","journal-title":"J. Healthcare Eng."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1385","series-title":"Injectable Biomaterials","first-page":"61","article-title":"4 - Improving mechanical properties of injectable polymers and composites","author":"Qiu","year":"2011"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1390","doi-asserted-by":"crossref","first-page":"6425","DOI":"10.1039\/c2nr31592k","article-title":"Delivering instilled hydrophobic drug to the bladder by a cationic nanoparticle and thermo-sensitive hydrogel composite system","volume":"4","author":"Men","year":"2012","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1395","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMra0804647","article-title":"Mechanisms of disease","volume":"361","author":"Abraham","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1400","doi-asserted-by":"crossref","first-page":"4280","DOI":"10.3748\/wjg.14.4280","article-title":"Role of cytokines in inflammatory bowel disease","volume":"14","author":"Sanchez-Mu\u00f1oz","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1405","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/nrgastro.2015.34","article-title":"Epidemiology and risk factors for IBD","volume":"12","author":"Ananthakrishnan","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1410","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.crohns.2013.01.010","article-title":"ECCO-EpiCom, the burden of inflammatory bowel disease in Europe","volume":"7","author":"Burisch","year":"2013","journal-title":"J. Crohn\u2019s Colitis"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1415","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1420","article-title":"Inflammatory bowel disease: an expanding global health problem","volume":"6","author":"M'koma","year":"2013","journal-title":"Clin. Med. Insights"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1425","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nrgastro.2016.208","article-title":"Current and emerging therapeutic targets for IBD","volume":"14","author":"Neurath","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1430","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1002\/jps.21216","article-title":"Alternative drug delivery approaches for the therapy of inflammatory bowel disease","volume":"97","author":"Meissner","year":"2008","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1435","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.3748\/wjg.15.4353","article-title":"5-ASA in ulcerative colitis: improving treatment compliance","volume":"15","author":"Prantera","year":"2009","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1440","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1517\/17425247.2.3.451","article-title":"Novel drug delivery strategies for the treatment of inflammatory bowel disease","volume":"2","author":"Kesisoglou","year":"2005","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1445","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(02)00004-2","article-title":"Colon-specific drug delivery: new approaches and in vitro\/in vivo evaluation","volume":"235","author":"Yang","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1450","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.addr.2004.08.011","article-title":"New oral delivery systems for treatment of inflammatory bowel disease","volume":"57","author":"Friend","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1455","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijpharm.2018.11.019","article-title":"Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice","volume":"554","author":"Gareb","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1460","first-page":"285","article-title":"Development of a pH-responsive particulate drug delivery vehicle for localized biologic therapy in inflammatory bowel disease","volume":"84","author":"Capurso","year":"2011","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1465","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2008.12.013","article-title":"pH-sensitive nanospheres for colon-specific drug delivery in experimentally induced colitis rat model","volume":"72","author":"Makhlof","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1470","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.biomaterials.2018.09.024","article-title":"Hierarchical structured and programmed vehicles deliver drugs locally to inflamed sites of intestine","volume":"185","author":"Li","year":"2018","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1475","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1211\/0022357001777315","article-title":"Colon delivery efficiencies of intestinal pressure-controlled colon delivery capsules prepared by a coating machine in human subjects","volume":"52","author":"Hu","year":"2000","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1480","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jconrel.2014.11.006","article-title":"In vivo efficacy of microbiota-sensitive coatings for colon targeting: a promising tool for IBD therapy","volume":"197","author":"Karrout","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1485","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.addr.2018.06.021","article-title":"Bioresponsive drug delivery systems in intestinal inflammation: state-of-the-art and future perspectives","volume":"146","author":"Kotla","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1490","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1136\/gut.2006.103564","article-title":"Risks and benefits of biologic therapy for inflammatory bowel diseases","volume":"56","author":"D\u2019Haens","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1495","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1136\/gut.2004.043372","article-title":"Guidelines for the management of inflammatory bowel disease in adults","volume":"53","author":"Carter","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1500","doi-asserted-by":"crossref","first-page":"300ra128","DOI":"10.1126\/scitranslmed.aaa5657","article-title":"An inflammation-targeting hydrogel for local drug delivery in inflammatory bowel disease","volume":"7","author":"Zhang","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1505","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1023\/B:PHAM.0000019298.29561.cd","article-title":"Differential adhesion of normal and inflamed rat colonic mucosa by charged liposomes","volume":"21","author":"Jubeh","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1510","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1021\/mp9000926","article-title":"Transferrin as a luminal target for negatively charged liposomes in the inflamed colonic mucosa","volume":"6","author":"Tirosh","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1515","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3390\/pharmaceutics10040188","article-title":"Ascorbyl palmitate hydrogel for local, intestinal delivery of macromolecules","volume":"10","author":"Zhai","year":"2018","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1520","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.actbio.2016.10.026","article-title":"Mucoadhesive chitosan hydrogels as rectal drug delivery vessels to treat ulcerative colitis","volume":"48","author":"Xu","year":"2017","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1525","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejps.2012.10.015","article-title":"Preparation and evaluation of mesalamine collagen in situ rectal gel: a novel therapeutic approach for treating ulcerative colitis","volume":"48","author":"Ramadass","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1530","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jbm.b.31289","article-title":"Release and activity of anti-TNF\u03b1 therapeutics from injectable chitosan preparations for local drug delivery","volume":"90","author":"Shamji","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1535","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/17434440.2019.1697229","article-title":"Colonic stents for malignant bowel obstruction: current status and future prospects","volume":"16","author":"Ormando","year":"2019","journal-title":"Expert Rev. Med. Dev."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1540","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.pnsc.2014.08.008","article-title":"Biodegradable intestinal stents: a review","volume":"24","author":"Wang","year":"2014","journal-title":"Progr. Nat. Sci. Mater. Int."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1545","first-page":"7","article-title":"Intestinal biodegradable stents","volume":"7","author":"Rejchrt","year":"2009","journal-title":"Folia Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1550","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1007\/s00330-011-2131-5","article-title":"Biodegradable polydioxanone stents: a new option for therapy-resistant anastomotic strictures of the colon","volume":"21","author":"Jan\u00edk","year":"2011","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1555","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4253\/wjge.v5.i5.265","article-title":"Biodegradable stent for the treatment of a colonic stricture in Crohn\u2019s disease","volume":"5","author":"Rodrigues","year":"2013","journal-title":"World J. Gastroint. Endosc."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1560","doi-asserted-by":"crossref","first-page":"E252","DOI":"10.1055\/s-0030-1256511","article-title":"Treatment of a benign colorectal anastomotic stricture with a biodegradable stent","volume":"43","author":"Toth","year":"2011","journal-title":"Endoscopy"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1565","first-page":"457","article-title":"Safety and efficacy of a novel plastic stent coated with stone-dissolving agents for the treatment of biliary stones in a porcine model","volume":"47","author":"Cai","year":"2015","journal-title":"Endoscopy"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1570","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1097\/MEG.0b013e328361eb51","article-title":"Interest of a new biodegradable stent coated with paclitaxel on anastomotic wound healing after biliary reconstruction","volume":"25","author":"Shi","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1575","doi-asserted-by":"crossref","first-page":"9451","DOI":"10.1016\/j.biomaterials.2013.08.055","article-title":"A 5-fluorouracil-loaded polydioxanone weft-knitted stent for the treatment of colorectal cancer","volume":"34","author":"Li","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1580","series-title":"Crohn\u2019s and Colitis Foundation of America","article-title":"Surgery for crohn\u2019s disease and ulcerative colitis","author":"C.s.a.C.F.o. America","year":"2020"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1585","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.3748\/wjg.14.2678","article-title":"Surgery for inflammatory bowel disease","volume":"14","author":"Hwang","year":"2008","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1590","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcmgh.2017.09.004","article-title":"Extracellular matrix bioscaffolds for building gastrointestinal tissue","volume":"5","author":"Hussey","year":"2018","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1595","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1067\/msy.2000.101584","article-title":"Inflammatory cytokines and cell response in surgery","volume":"127","author":"Lin","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1600","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s13346-016-0305-z","article-title":"Controlled release drug delivery systems to improve post-operative pharmacotherapy","volume":"6","author":"Bhusal","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1605","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1136\/bmj.316.7141.1390","article-title":"Non-steroidal anti-inflammatories should not be used after orthopaedic surgery","volume":"316","author":"Varghese","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1610","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0161-6420(99)90060-X","article-title":"Randomized clinical trial of a new dexamethasone delivery system (Surodex) for treatment of post-cataract surgery inflammation","volume":"106","author":"Tan","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1615","first-page":"317","article-title":"Sustained release intraocular drug delivery devices for treatment of uveitis","volume":"6","author":"Haghjou","year":"2011","journal-title":"J. Ophthalmic Vision Res."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1620","series-title":"Seminars in Plastic Surgery","first-page":"133","article-title":"Orthognathic surgery-general considerations","author":"Khechoyan","year":"2013"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1625","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1208\/s12249-009-9308-0","article-title":"Organic\u2013inorganic composites for bone drug delivery","volume":"10","author":"Soundrapandian","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1630","doi-asserted-by":"crossref","DOI":"10.1615\/JLongTermEffMedImplants.v21.i2.10","article-title":"Short-term and long-term effects of orthopedic biodegradable implants","volume":"21","author":"Amini","year":"2011","journal-title":"J. Long-Term Eff. Med. Implants"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1635","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.matlet.2014.06.070","article-title":"Biodegradable Bi-layered coating on polymeric orthopaedic implants for controlled release of drugs","volume":"132","author":"Argarate","year":"2014","journal-title":"Mater. Lett."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1640","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biomaterials.2019.05.014","article-title":"Triple-functional polyetheretherketone surface with enhanced bacteriostasis and anti-inflammatory and osseointegrative properties for implant application","volume":"212","author":"Xu","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1645","article-title":"The global impact of respiratory disease","author":"Marciniuk","year":"2017","journal-title":"Eur. Respir. Soc."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1650","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/qhc.11.4.376","article-title":"Inhaler devices for the treatment of asthma and chronic obstructive airways disease (COPD)","volume":"11","author":"Wright","year":"2002","journal-title":"Qual. Saf. Health Care"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1655","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/rccm.200508-1321OC","article-title":"Antiinflammatory effects of salmeterol\/fluticasone propionate in chronic obstructive lung disease","volume":"173","author":"Barnes","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1660","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/1817-1737.140120","article-title":"Corticosteroids in the treatment of acute asthma","volume":"9","author":"Alangari","year":"2014","journal-title":"Ann. Thorac. Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1665","first-page":"2732017","article-title":"Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes","volume":"2018","author":"Borghardt","year":"2018","journal-title":"Can. Respir. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1670","series-title":"Arnuity Ellipta-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1675","series-title":"QVAR\u00ae RedihalerTM-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2000"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1680","series-title":"Pulmicort Respules\u00ae-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2000"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1685","series-title":"Pulmicort FlexhalerTM-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2006"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1690","series-title":"Asmanex\u00ae HFA - Prescribing Information","author":"U.S. Food and Drug Administration","year":"2014"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1695","series-title":"Alvesco\u00ae- Prescribing Information","author":"U.S. Food and Drug Administration","year":"2006"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1700","series-title":"Symbicort-Product Label","author":"U.S. Food and Drug Administration","year":"2006"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1705","series-title":"Dulera\u00ae-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2010"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1710","series-title":"BREO Ellipta-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2013"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1715","series-title":"Trelegy Ellipta-Prescribing Information","author":"U.S. Food and Drug Administration","year":"2017"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1720","series-title":"ADVAIR Diskus-Product Information","author":"U.S. Food and Drug Administration","year":"2000"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1725","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1517\/17425247.2015.993968","article-title":"Pulmonary delivery of anti-inflammatory agents","volume":"12","author":"Ali","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1730","series-title":"Targeting Chronic Inflammatory Lung Diseases Using Advanced Drug Delivery Systems","first-page":"57","article-title":"Novel drug delivery systems and significance in respiratory diseases","author":"Mishra","year":"2020"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1735","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.ccm.2013.05.003","article-title":"Tracheobronchomalacia and excessive dynamic airway collapse","volume":"34","author":"Murgu","year":"2013","journal-title":"Clin. Chest Med."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1740","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00330-009-1306-9","article-title":"Airway malacia in chronic obstructive pulmonary disease: prevalence, morphology and relationship with emphysema, bronchiectasis and bronchial wall thickening","volume":"19","author":"Sverzellati","year":"2009","journal-title":"Eur. Radiol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1745","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.pharmthera.2017.05.007","article-title":"Emerging bronchoscopic treatments for chronic obstructive pulmonary disease","volume":"179","author":"van Geffen","year":"2017","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1750","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/resp.13801","article-title":"Airway stenting: technological advancements and its role in interventional pulmonology","volume":"25","author":"Guibert","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1755","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/03639045.2018.1522325","article-title":"The utility of 3D-printed airway stents to improve treatment strategies for central airway obstructions","volume":"45","author":"Xu","year":"2019","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1760","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.chest.2016.03.001","article-title":"Three-dimensional printing and 3D slicer: powerful tools in understanding and treating structural lung disease","volume":"149","author":"Cheng","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1765","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1378\/chest.12-2282","article-title":"Biodegradable cisplatin-eluting tracheal stent for malignant airway obstruction: in vivo and in vitro studies","volume":"144","author":"Chao","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1770","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.4103\/0366-6999.193461","article-title":"Paclitaxel drug-eluting tracheal stent could reduce granulation tissue formation in a canine model","volume":"129","author":"Wang","year":"2016","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1775","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7150\/jca.13611","article-title":"Drug eluting stents for malignant airway obstruction: a critical review of the literature","volume":"7","author":"Hohenforst-Schmidt","year":"2016","journal-title":"J. Cancer"},{"key":"10.1016\/j.jconrel.2020.12.025_bb1780","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016","author":"Rider","year":"2016","journal-title":"Int. J. Cell Biol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1785","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.coph.2010.01.005","article-title":"Pharmacology of TNF blockade in rheumatoid arthritis and other chronic inflammatory diseases","volume":"10","author":"Taylor","year":"2010","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1790","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1586\/1744666X.2015.1010517","article-title":"Emerging biologics for the treatment of chronic rhinosinusitis","volume":"11","author":"Pauwels","year":"2015","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1795","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bpg.2010.01.002","article-title":"Adverse effects of biologics used for treating IBD","volume":"24","author":"Stallmach","year":"2010","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1800","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.3390\/ijms19082244","article-title":"Anti-TNF therapy in Crohn\u2019s disease","volume":"19","author":"Adegbola","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1805","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3389\/fphar.2017.00460","article-title":"Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics","volume":"8","author":"Li","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1810","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1167\/tvst.5.2.11","article-title":"A drug delivery system for administration of anti\u2013TNF-\u03b1 antibody","volume":"5","author":"Robert","year":"2016","journal-title":"Transl. Vision Sci. Technol."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1815","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.spinee.2015.04.026","article-title":"Fibrin-genipin annulus fibrosus sealant as a delivery system for anti-TNFalpha drug","volume":"15","author":"Likhitpanichkul","year":"2015","journal-title":"Spine J."},{"key":"10.1016\/j.jconrel.2020.12.025_bb1820","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biomaterials.2019.02.017","article-title":"Hydrogel-based delivery of Il-10 improves treatment of bleomycin-induced lung fibrosis in mice","volume":"203","author":"Shamskhou","year":"2019","journal-title":"Biomaterials"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920307495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365920307495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:57:53Z","timestamp":1759161473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365920307495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":359,"alternative-id":["S0168365920307495"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.025","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Local drug delivery systems for inflammatory diseases: Status quo, challenges, and opportunities","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2020.12.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}